GMT Genomtec S.A.

3.170PLN+5.14%Mkt Cap: 13.70M $P/E: —

Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland. The company's flagship project is the Genomtec ID, a diagnostic platform that enables t…

Key Statistics

Company
Market Cap13.70M USD
Enterprise Value11.81M USD
Revenue (TTM)7.60K USD
Gross Profit-2.02M USD
Net Income (TTM)-2.64M USD
Revenue/Share0.0020 PLN
Last Price3.170 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees32
CountryPL
SectorHealthcare
IndustryMedical Devices
ISINPLGNMTC00017
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-7.69
EV/Revenue1554.48
P/S1715.00
P/B4.82
EPS (TTM)-0.62
EPS (Forward)—
52W Range
3.0004% of range7.330
52W High7.330 PLN
52W Low3.000 PLN
Profitability
Gross Margin-37909.52%
Oper. Margin-13387.50%
EBITDA Margin0.00%
Profit Margin-49671.43%
ROE-113.21%
ROA-67.92%
Growth
Revenue Growth220.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.83M USD
CapEx (TTM)23.30K USD
FCF Margin-22987.50%
FCF Yield-12.75%
Net Debt-188.43K USD
Net Debt/EBITDA0.12
Balance Sheet
Debt/Equity0.21
Current Ratio1.77
Quick Ratio1.52
Book Value/Sh0.63 PLN
Cash/Share0.17 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.17.06M
Float9.77M
Insiders15.37%
Institutions2.93%
Technical
SMA 503.709 (-14.5%)
SMA 2004.507 (-29.7%)
Beta0.31
S&P 52W Chg14.58%
Avg Vol (30d)17.56K
Avg Vol (10d)23.38K
Technical Indicators
RSI (14)32.5
MACD-0.1765
MACD Signal-0.1433
MACD Hist.-0.0332
BB Upper3.906 PLN
BB Middle3.486 PLN
BB Lower3.067 PLN
BB Width24.07%
ATR (14)0.1573 PLN
Vol Ratio (20d)0.75x